about
EXT-mutation analysis and loss of heterozygosity in sporadic and hereditary osteochondromas and secondary chondrosarcomas.The clinical approach toward giant cell tumor of boneLymphatic and other vascular malformative/overgrowth disorders are caused by somatic mutations in PIK3CAMultiple statistical analysis techniques corroborate intratumor heterogeneity in imaging mass spectrometry datasets of myxofibrosarcomaLoss-of-function mutations in PTPN11 cause metachondromatosis, but not Ollier disease or Maffucci syndrome.Carbon and Sulfur Cycling below the Chemocline in a Meromictic Lake and the Identification of a Novel Taxonomic Lineage in the FCB Superphylum, Candidatus Aegiribacteria.Ring chromosome 4 as the sole cytogenetic anomaly in a chondroblastoma: a case report and review of the literature.Molecular pathology and its diagnostic use in bone tumors.Hierarchical clustering of flow cytometry data for the study of conventional central chondrosarcoma.Tissue factor associates with survival and regulates tumour progression in osteosarcoma.Molecular pathology of sarcomas: concepts and clinical implicationsEXTra hit for mouse osteochondroma.Chondrosarcoma of the phalanx: a locally aggressive lesion with minimal metastatic potential: a report of 35 cases and a review of the literature.Opening the archives for state of the art tumour genetic research: sample processing for array-CGH using decalcified, formalin-fixed, paraffin-embedded tissue-derived DNA samplesAn update of diagnostic strategies using molecular genetic and magnetic resonance imaging techniques for musculoskeletal tumors.Genes involved in the osteoarthritis process identified through genome wide expression analysis in articular cartilage; the RAAK study.Enchondromatosis: insights on the different subtypes.EGFR and KRAS quality assurance schemes in pathology: generating normative data for molecular predictive marker analysis in targeted therapy.Comprehensive analysis of published studies involving systemic treatment for chondrosarcoma of bone between 2000 and 2013.GRM1 is upregulated through gene fusion and promoter swapping in chondromyxoid fibroma.Diagnosis and prognosis of chondrosarcoma of bone.Primary vascular tumors of bone: a spectrum of entities?Expression of the immune regulation antigen CD70 in osteosarcoma.Periosteal chondrosarcoma: a histopathological and molecular analysis of a rare chondrosarcoma subtype.Incidence, predictive factors, and prognosis of chondrosarcoma in patients with Ollier disease and Maffucci syndrome: an international multicenter study of 161 patientsPitfalls in pathology of soft tissue sarcomas.Near-haploidy and subsequent polyploidization characterize the progression of peripheral chondrosarcoma.Histology-Guided High-Resolution Matrix-Assisted Laser Desorption Ionization Mass Spectrometry Imaging.Reclassification and subtyping of so-called malignant fibrous histiocytoma of bone: comparison with cytogenetic features.Linkage-Specific in Situ Sialic Acid Derivatization for N-Glycan Mass Spectrometry Imaging of Formalin-Fixed Paraffin-Embedded Tissues.NR4A3 rearrangement reliably distinguishes between the clinicopathologically overlapping entities myoepithelial carcinoma of soft tissue and cellular extraskeletal myxoid chondrosarcoma.Cell cycle deregulation and mosaic loss of Ext1 drive peripheral chondrosarcomagenesis in the mouse and reveal an intrinsic cilia deficiencyMultimodal Mass Spectrometry Imaging of N-Glycans and Proteins from the Same Tissue Section.No preclinical rationale for IGF1R directed therapy in chondrosarcoma of boneCORR Insights(®): Transcriptional Profiling Identifies the Signaling Axes of IGF and Transforming Growth Factor-β as Involved in the Pathogenesis of Osteosarcoma.Identification and systematic annotation of tissue-specific differentially methylated regions using the Illumina 450k array.Establishment and characterization of a new human myxoid liposarcoma cell line (DL-221) with the FUS-DDIT3 translocation.Extra-abdominal subcutaneous metastasis of a gastrointestinal stromal tumor: report of a case and a review of the literature.Cartilage tumours and bone development: molecular pathology and possible therapeutic targets.Malignant fibrous histiocytoma and fibrosarcoma of bone: a re-assessment in the light of currently employed morphological, immunohistochemical and molecular approaches.
P50
Q24540139-3DD754E9-A1E4-4F65-AD68-6E471F223E57Q27024555-50758440-4DC0-473D-9869-40001165BDA7Q28256964-FCE76864-8AD1-4389-A71A-870725882AE5Q28477284-1FB62AC0-7A56-4E54-9E1F-10C5D8D54530Q30475729-1589412D-4428-4F70-B53F-2D3D0842B353Q31097568-6D3B3BF5-C9B4-4BE7-B031-317764E37260Q32030636-54B21286-6F46-43B2-A5C6-17F6B13DFE72Q33274485-E91182C6-419C-4632-8A29-B40B7C933850Q33588797-C8F2AFE0-F18D-40E8-937B-CBE1559C00F4Q33672303-0C9BCACD-2370-41FC-A72A-7E6B384096F3Q33688157-EE32E1EE-06E3-4B0D-82F6-BF037E8770A8Q33720003-7EF4A6AF-055E-4697-9810-4083A81291E9Q33765771-9EC69CD1-E388-4F4E-916E-54004C6FC82CQ33785386-DA822D9C-F298-428D-8937-8520D9F285BEQ33824811-82ADE42C-7C3B-4481-B2A2-0C4E8D10557DQ33940184-8A7AA32E-601E-461E-A83C-771C8AEB1B01Q34007437-7D1EC615-A31D-4513-BDFB-B0E9B79B1129Q34030464-3A3139FA-D29B-45ED-A979-FCF3EA3BCF11Q34038664-F8AF612F-F609-496C-AD12-27B676DB382FQ34411505-A957EEFD-82FE-45DF-872B-5411DEE83CD8Q34884702-8816729B-6310-475D-899F-F7AC991E2D94Q35178177-CFE0580F-AFE6-473C-8083-9484E8651CA3Q35194116-B73312E5-8D93-4C5B-8EDC-73BB95A40011Q35554575-43AEE779-640F-484D-886B-D3145B2926B8Q35642393-365F2AF9-2B53-4A37-80A2-DFE500D489C0Q35816964-61663AFF-438A-4ECD-BD7A-776D6B35144CQ35829605-14B8AD41-F36C-443B-BA96-6D22E0887629Q35848629-3FAD5DBA-BCFA-4962-9BF7-548511849753Q35958092-468E408A-D815-4748-A112-A85BAAE57847Q36008391-2555F5E6-D8A6-4A5F-84B6-098E20F9AE96Q36020598-1F7AAC4C-3A44-412F-9A7E-C7AEB074422FQ36041855-538A191B-8947-4863-A222-29D492CA55E5Q36066970-FCB5D76B-7D7E-4337-B60C-FAC0B3372F62Q36078319-AB14F78E-BACA-4459-86EB-4AF3FFDD3702Q36391563-12993F70-531F-49EF-8032-1CC0A646A75AQ37113642-690723A5-7F11-4E8B-A2F3-517D941736F0Q37136357-E614A30A-D077-45C9-A2C1-4243F56ADDD0Q37498969-94D0B310-8842-4171-960F-C2737C17FDC9Q37763842-52D93890-AA5A-4072-9219-D9BB5F2834C4Q38045777-72251E38-92DA-48C5-823B-D10F02438502
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Judith Vmg Bovée
@ast
Judith Vmg Bovée
@en
Judith Vmg Bovée
@es
Judith Vmg Bovée
@nl
type
label
Judith Vmg Bovée
@ast
Judith Vmg Bovée
@en
Judith Vmg Bovée
@es
Judith Vmg Bovée
@nl
altLabel
J.V. Bovée
@nl
prefLabel
Judith Vmg Bovée
@ast
Judith Vmg Bovée
@en
Judith Vmg Bovée
@es
Judith Vmg Bovée
@nl
P106
P21
P31
P496
0000-0003-1155-0481
P735
P7449
PRS1292447